Range Low Price High Price Comment
30 days JP¥16.00 JP¥21.00 Wednesday, 1st May 2024 4564.T stock ended at JP¥18.00. This is 5.88% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 12.50% from a day low at JP¥16.00 to a day high of JP¥18.00.
90 days JP¥16.00 JP¥24.00
52 weeks JP¥16.00 JP¥45.00

Historical OncoTherapy Science,Inc. prices

Date Open High Low Close Volume
May 01, 2024 JP¥17.00 JP¥18.00 JP¥16.00 JP¥18.00 4 625 500
Apr 30, 2024 JP¥17.00 JP¥18.00 JP¥17.00 JP¥17.00 2 162 000
Apr 26, 2024 JP¥18.00 JP¥19.00 JP¥17.00 JP¥17.00 5 666 000
Apr 25, 2024 JP¥19.00 JP¥19.00 JP¥18.00 JP¥18.00 3 194 200
Apr 24, 2024 JP¥19.00 JP¥20.00 JP¥19.00 JP¥19.00 2 604 900
Apr 23, 2024 JP¥20.00 JP¥20.00 JP¥19.00 JP¥19.00 2 248 500
Apr 22, 2024 JP¥19.00 JP¥20.00 JP¥18.00 JP¥19.00 3 319 200
Apr 19, 2024 JP¥20.00 JP¥20.00 JP¥18.00 JP¥19.00 4 016 700
Apr 18, 2024 JP¥19.00 JP¥20.00 JP¥19.00 JP¥19.00 2 276 800
Apr 17, 2024 JP¥20.00 JP¥20.00 JP¥19.00 JP¥20.00 1 990 700
Apr 16, 2024 JP¥20.00 JP¥20.00 JP¥19.00 JP¥20.00 2 152 100
Apr 15, 2024 JP¥20.00 JP¥20.00 JP¥19.00 JP¥20.00 2 368 800
Apr 12, 2024 JP¥20.00 JP¥21.00 JP¥19.00 JP¥21.00 3 512 500
Apr 11, 2024 JP¥20.00 JP¥21.00 JP¥19.00 JP¥21.00 3 515 500
Apr 10, 2024 JP¥19.00 JP¥20.00 JP¥19.00 JP¥20.00 1 987 400
Apr 09, 2024 JP¥18.00 JP¥20.00 JP¥18.00 JP¥19.00 2 778 200
Apr 08, 2024 JP¥19.00 JP¥19.00 JP¥18.00 JP¥19.00 2 465 800
Apr 05, 2024 JP¥19.00 JP¥20.00 JP¥18.00 JP¥19.00 2 685 800
Apr 04, 2024 JP¥19.00 JP¥20.00 JP¥19.00 JP¥19.00 2 919 800
Apr 03, 2024 JP¥19.00 JP¥20.00 JP¥18.00 JP¥19.00 4 849 500
Apr 02, 2024 JP¥21.00 JP¥21.00 JP¥19.00 JP¥19.00 3 396 800
Apr 01, 2024 JP¥21.00 JP¥21.00 JP¥20.00 JP¥20.00 1 807 500
Mar 29, 2024 JP¥20.00 JP¥21.00 JP¥20.00 JP¥20.00 1 015 400
Mar 28, 2024 JP¥20.00 JP¥21.00 JP¥20.00 JP¥20.00 897 400
Mar 27, 2024 JP¥20.00 JP¥21.00 JP¥20.00 JP¥20.00 656 900
Click to get the best stock tips daily for free!

About OncoTherapy Science,Inc.

OncoTherapy ScienceInc. OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinical trials for the treatment of breast cancer; and OTS964, a T-LAK cell-originated protein kinase inhi... 4564.T Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT